BHCM
RGNX icon

Brevan Howard Capital Management’s Regenxbio RGNX Stock Holding History

Brevan Howard Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Buy
33,177
+14,275
+76% +$118K ﹤0.01% 1555
2026
Q1 		$158K Buy
18,902
+2,062
+12% +$21.7K ﹤0.01% 1951
2025
Q4 		$242K Buy
16,840
+448
+3% +$5.58K ﹤0.01% 1484
2025
Q3 		$158K Buy
+16,392
New +$145K ﹤0.01% 1803
2025
Q2 		– Sell
-17,373
Closed -$124K – 1985
2025
Q1 		$124K Sell
17,373
-23,787
-58% -$177K ﹤0.01% 1037
2024
Q4 		$318K Buy
+41,160
New +$386K ﹤0.01% 753
2024
Q3 		– Sell
-15,222
Closed -$178K – 1387
2024
Q2 		$178K Buy
+15,222
New +$237K ﹤0.01% 916

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Brevan Howard Capital Management's RGNX Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Regenxbio (RGNX) stake by 76% in Q2 2026, buying an estimated $118K and bringing the position to 33,177 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #1555.

Brevan Howard Capital Management first reported a position in RGNX in Q2 2024 and has held it in 7 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Brevan Howard Capital Management held 33,177 shares of Regenxbio worth $397K as of Q2 2026.
  • Brevan Howard Capital Management bought 14,275 Regenxbio shares in Q2 2026, an estimated $118K.
  • Regenxbio made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1555 holding.
  • Brevan Howard Capital Management first reported a position in Regenxbio in Q2 2024 and has held it in 7 quarters since.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.